Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | MME | P08473 | 3/20 | 0.57 |
| ▸ | ECE1 | P42892 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | PLG | P00747 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7436159 | 1.00 | NMBR (0.62) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL10899582 | 1.00 | NMBR (0.62) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL3072927 | 0.96 | NMBR (0.63) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL27738734 | 0.96 | NMBR (0.63) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL10972700 | 0.94 | NMBR (0.61) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL10968279 | 0.93 | NMBR (0.68) | NMBRMAPTGAAHTTMME | |
| SCHEMBL3065558 | 0.92 | PLG (0.63) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL4941526 | 0.91 | NMBR (0.59) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL10968949 | 0.90 | NMBR (0.58) | NMBRKMT2AMEN1MAPTGAA | |
| SCHEMBL8197468 | 0.90 | TGM2 (0.65) | NMBRKMT2AMEN1MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2983473-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS Mountain Llc (US) | 2016-02-17 | — | — | EP | claimed |
| US-20140350064-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC | 2014-11-27 | — | — | US | claimed |
| WO-2014144130-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC (US) | 2014-09-18 | — | — | WO | claimed |
| US-20120183600-A1 | NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS | CHEN CHIEN-HUNG (US) | 2012-07-19 | — | — | US | claimed |
| EP-1789052-A4 | COMPOSITION AND METHOD FOR INDUCING OR RESTORING LOCOMOTOR FUNCTIONS IN AN ANIMAL | UNIV LAVAL (CA) | 2008-05-21 | — | — | EP | claimed |
| US-20080096847-A1 | Composition And Method For Inducing Or Restoring Locomotor Functions In An Animal | UNIVERSITE LAVAL | 2008-04-24 | — | — | US | claimed |
| EP-1789052-A1 | COMPOSITION AND METHOD FOR INDUCING OR RESTORING LOCOMOTOR FUNCTIONS IN AN ANIMAL | Université Laval (CA) | 2007-05-30 | — | — | EP | claimed |
| WO-2006026850-A1 | COMPOSITION AND METHOD FOR INDUCING OR RESTORING LOCOMOTOR FUNCTIONS IN AN ANIMAL | UNIVERSITE LAVAL (CA) | 2006-03-16 | — | — | WO | claimed |
| US-20030187055-A1 | Synergistic pharmaceutical combinations for treating obesity | BANK OF AMERICA, N.A., AS AGENT | 2003-10-02 | — | — | US | claimed |
| US-20030162725-A1 | Synergistic pharmaceutical combinations for treating obesity with EGCG | BANK OF AMERICA, N.A., AS AGENT | 2003-08-28 | — | — | US | claimed |
| US-6579899-B1 | Precursor or prodrug of serotonin, tryptophan or 5-hydroxytryptophan | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2003-06-17 | — | — | US | claimed |
| WO-2002038141-A9 | COMPOSITIONS AND METHODS FOR TREATMENT OF MILD COGNITIVE IMPAIRMENT | MASSACHUSETTS INST TECHNOLOGY (US) | 2003-02-13 | — | — | WO | claimed |
| US-20020173549-A1 | Compositions and methods for treatment of mild cognitive impairment | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-11-21 | — | — | US | claimed |
| EP-1253915-A1 | METHOD FOR TREATING STRESS WITH A PRECURSOR OF SEROTONIN | Massachusetts Institute of Technology (US) | 2002-11-06 | — | — | EP | claimed |
| WO-2002038141-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF MILD COGNITIVE IMPAIRMENT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-05-16 | — | — | WO | claimed |
| WO-2001054681-A2 | COMPOSITION FOR TREATMENT OF STRESS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2001-08-02 | — | — | WO | claimed |
| US-9315483-B2 | Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof | CONCERT PHARMACEUTICALS, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| EP-2983473-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS Mountain Llc (US) | 2016-02-17 | — | — | EP | disclosed |
| EP-0237082-A2 | 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | SYNTEX (U.S.A.) INC. (US) | 1987-09-16 | — | — | EP | disclosed |
| US-4518587-A | NERVOUS SYSTEM DISORDERS | S.A. PANMEDICA (FR) | 1985-05-21 | — | — | US | disclosed |